共 108 条
[1]
*ABB LAB, 1997, PROD INS
[2]
COMPARATIVE BIOAVAILABILITY OF ISONIAZID, RIFAMPIN, AND PYRAZINAMIDE ADMINISTERED IN FREE COMBINATION AND IN A FIXED TRIPLE FORMULATION DESIGNED FOR DAILY USE IN ANTITUBERCULOSIS CHEMOTHERAPY .2. 2-MONTH, DAILY ADMINISTRATION STUDY
[J].
AMERICAN REVIEW OF RESPIRATORY DISEASE,
1988, 138 (04)
:886-890
[4]
AMEER B, 1982, Clinical Pharmacy, V1, P156
[7]
BENEDEK IH, 1998, 12 WORLD AIDS C, P829
[8]
Benedek IH, 1998, CLIN INFECT DIS, V27, P1008
[9]
Benson Constance A., 1997, American Journal of Medicine, V102, P32
[10]
BERNING SE, 1992, NEW ENGL J MED, V327, P1817, DOI 10.1056/NEJM199212173272514